000 | 01384 a2200409 4500 | ||
---|---|---|---|
005 | 20250512014629.0 | ||
264 | 0 | _c19890713 | |
008 | 198907s 0 0 eng d | ||
022 | _a0143-3636 | ||
024 | 7 |
_a10.1097/00006231-198903000-00004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCrowther, M E | |
245 | 0 | 0 |
_aTherapeutic considerations in the use of intraperitoneal radiolabelled monoclonal antibodies in ovarian carcinoma. _h[electronic resource] |
260 |
_bNuclear medicine communications _cMar 1989 |
||
300 |
_a149-59 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
650 | 0 | 4 |
_aCatheters, Indwelling _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntestinal Diseases _xetiology |
650 | 0 | 4 | _aIodine Radioisotopes |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aOvarian Neoplasms _xpathology |
650 | 0 | 4 |
_aPeritoneal Neoplasms _xpathology |
700 | 1 | _aWard, B G | |
700 | 1 | _aGranowska, M | |
700 | 1 | _aMather, S | |
700 | 1 | _aBritton, K E | |
700 | 1 | _aShepherd, J H | |
700 | 1 | _aSlevin, M L | |
773 | 0 |
_tNuclear medicine communications _gvol. 10 _gno. 3 _gp. 149-59 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00006231-198903000-00004 _zAvailable from publisher's website |
999 |
_c2731975 _d2731975 |